Article & Resources

transparent image

Low Dose Rate Brachytherapy for Localised Carcinoma of the Prostate

transparent image

September Events

transparent image

Raymond Kirkham: Prostate Cancer Journey

transparent image

New Research: Exploring the implications of Transrectal Prostate Biopsies

transparent image

The role of radiation therapy in prostate cancer in New Zealand

transparent image

A Prostate Cancer story: Paul Ricketts

transparent image

Why Men Must Research Their Prostate Cancer Treatment Options

transparent image

BXTAccelyon Newsletter February 2021

transparent image

World Cancer Day: Men Must Act Now

transparent image

BXTAccelyon verhoogt opnieuw zijn inzet voor Europese expansie met een nieuwe locatie in Nederland

transparent image

BXTAccelyon increases commitment to European expansion with new locations in the Netherlands

transparent image

Tom Wolf gets the all-clear

transparent image

BAUN Conference highlight: “Nurses are key to eradicating transrectal prostate biopsy”

transparent image

Focus on Focal Therapy – for the treatment of prostate cancer

transparent image

A new, independent report from the York Health Economics Consortium (YHEC) on prostate cancer biopsies, has validated the improved health outcomes and economic benefits of the PrecisionPointTM transperineal prostate biopsy methodology under local anaesthetic (LA TP).

transparent image

Continued access to healthcare education with virtual technology

transparent image

My dad had prostate cancer when he was 65. Does this make me more likely to get it too? What could increase my risk and how will I know if I have it?

transparent image

BXTA welcomes European Commercial Leader & Clinical Applications Specialist team members amidst continued international growth.

transparent image

Prostate Cancer: Know the early warning signs

transparent image

What every couple should know about prostate cancer

transparent image

Nurse-led service transformation: a pathway to professional advancement – and better patient care

transparent image

BXTAccelyon wins 2020 MedTech Breakthrough Award

transparent image

Prostate biopsy: a change of approach

transparent image

What every couple should know about prostate cancer…

transparent image

The ‘Fry‐Turnbull’ effect

transparent image

A new research paper recently published gives further weight to the eradication of the transrectal (TR) prostate biopsy from the prostate cancer pathway.

transparent image

New study adds evidence to the important role of MRI & systematic biopsy in prostate cancer diagnosis

transparent image

Patients treated with Low Dose Rate Brachytherapy boost therapy in combination with External Beam Radiotherapy achieve more effective PSA control

transparent image

The influential role of brachytherapy in prostate cancer care

transparent image

Like Bill Turnbull and Stephen Fry, Russell is keen to make more men aware of the importance of getting themselves checked early and regularly.

transparent image

David Robb was a 68-year-old retired secondary school teacher from Peebles, Scotland when he was diagnosed with prostate cancer last Summer.

transparent image

“Before having a prostate cancer biopsy, I’d demand an MRI scan”

transparent image

Cancer alliance moves towards the eradication of Trus prostate cancer biopsy

transparent image

Prostate Cancer won’t wait for the pandemic to end

transparent image

THE SOUTH WEST CANCER ALLIANCE MOVES TOWARDS ERADICATION OF ‘TRUS’ PROSTATE CANCER BIOPSY

transparent image

Risk and Reward: why the specialist urology nurse is a role worth fighting for

transparent image

BXTAccelyon and Hitachi Medical Systems to support #TRexit

transparent image

BXTACCELYON BECOMES GLOBAL DISTRIBUTION PARTNER FOR NEW ONLINE PROSTATE MRI SELF-LEARNING TOOL, MRI PRO, TO ENHANCE PROSTATE CANCER DIAGNOSIS

transparent image

“TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now

transparent image

State of the Art Stokes Centre for Urology to host Two-day Uro-Oncology Masterclass covering latest Innovations in Prostate Cancer Pathway

transparent image

Proton therapy for prostate cancer: does the evidence support the hype?

transparent image

All men with suspected prostate cancer should be offered a specialist MRI scan when they’re referred to the hospital in England, before a biopsy.

transparent image

Forget Brexit, it’s all about TRexit – and urology nurses are leading the way

transparent image

The National Prostate Cancer Audit (NPCA) published results

transparent image

LDR Brachytherapy – Latest study indicates acceptable GU toxicity in patients with prostate cancer treated with permanent seed implantation (PI)

transparent image

BXTAccelyon welcomes Kalpesh Makvana to the team

transparent image

Exemplary customer service from the team at BXTAccelyon

transparent image

BXTAccelyon addresses concerns that patients may be misled by news of HDR brachytherapy monotreatment

transparent image

Prostate cancer in Scotland: an evolutionary journey By Karen Walker, Clinical Nurse Specialist,Edinburgh Cancer Centre

transparent image

Chris was diagnosed with prostate cancer at the age of 67, having previously been treated for testicular cancer in 1976. His treatment pathway took many turns and below is his story.

transparent image

Open Letter to the Rt Hon Matt Hancock MP – Re: Time for ‘TREXIT’

transparent image

First PP course for Urology Nurses Practitioners and Registrars

transparent image

Daily Express – PSA Test Awareness

transparent image

Chris Stone, 66 – A Patient Experience

transparent image

Time for change: Trexit

transparent image

Kevin Darragh began his prostate cancer treatment journey back in December 2012. After researching and discussing treatment options with those close to him, Kevin decided on brachytherapy

transparent image

John Morris’ story is an example of how far prostate cancer diagnosis and treatment, as well as men’s attitudes to the disease, have evolved in the last 10 years. It also proves the validity of low dose rate brachytherapy (LDR-B) as a long-standing, clinically proven treatment option with minimal quality of live side effects compared to other treatments

transparent image

BXTAccelyon attend the 9th Annual Urology in General Practice (UroGP) Symposium 2018

transparent image

LDR Brachytherapy: A minimally invasive curative treatment with excellent oncological and functional outcomes

transparent image

Galway’s success challenges common preconceptions about LDR brachytherapy

transparent image

Prostate Cancer: Men need to be given more control over their treatment options

transparent image

BXTAccelyon’s programme of upcoming events

transparent image

Prostate cancer Awareness Month – Australia

transparent image

Taxi for cancer: Cab driver Andy hails the day a fare saved his life

transparent image

Making informed treatment decisions

transparent image

The NHS turns 70!

transparent image

Challenging default clinical practice for prostate cancer

transparent image

BXTAccelyon set to exhibit at BAUS 2018

transparent image

Better Quality of life scores after brachytherapy in comparison to radical prostatectomy

transparent image

Theresa May’s announcement of £75m plans to drive prostate cancer research

transparent image

The influential role of GPs – and brachytherapy – in prostate cancer care

transparent image

Ascending to the Next Level

transparent image

Maidstone Hospital is this year’s host for the UK & Ireland Prostate Brachytherapy Conference

transparent image

Treatment options for patients with prostate cancer – GPs meeting

transparent image

New medical device received therapeutic goods administration (TGA) approval

transparent image

Cost effectiveness study highlights benefits of new ‘4D’ technique for low dose rate brachytherapy

transparent image

Dismissal of ASCENDE-RT LDR boost findings restricts life-enhancing treatment opportunities

transparent image

59% of prostate cancer patients receive treatment without understanding their treatment options

transparent image

Low Dose Rate Brachytherapy Boost: Latest Scientific Evidence on Outcome Survival Rates Indicates LD

transparent image

Sowing the seeds of knowledge in brachytherapy

transparent image

BXTAccelyon to host Benelux LDR Brachytherapy event endorsed by ABRO/BVRO

transparent image

Prostate cancer: Know your treatment options

transparent image

BXTAccelyon becomes sole distribution partner for new transperineal prostate biopsy device

transparent image

Prostate Cancer: men should be given wider access to treatment options available

transparent image

PrecisionPoint™ Transperineal Access System – New Zealand workshops

transparent image

The crucial role of a Clinical Nurse Specialist (CNS)

transparent image

Upcoming events, workshops and conferences

transparent image

BXTAccelyon named as one of the Top 50 Prostate Cancer Blogs on the planet!

transparent image

BXTAccelyon support new urology centre

transparent image

BXTAccelyon is attending UroGP 2017 in Melbourne!

transparent image

The Prostate Brachytherapy UK and Ireland Conference 2017

transparent image

BXTAccelyon newsletter: June 2017

transparent image

Prostate cancer procedure one day, golf the next

transparent image

Our latest commentary on Robotic Surgery for Prostate Cancer

transparent image

BXTAccelyon continues its commitment to growth

transparent image

More men in Northern Ireland surviving prostate cancer

transparent image

Active Surveillance or Another Prostate Cancer Treatment? Choices Linked to Quality of Life

transparent image

Prostate Cancer: Men have more control over treatment options then they might think

transparent image

Slade star undergoes brachytherapy to treat prostate cancer

transparent image

Case study: a new approach to prostate cancer treatment

transparent image

Lack of PSA testing leads to Metastatic Prostate Cancer Diagnosis Rise in the US

transparent image

Inside Health – BBC Radio 4 discusses uncertainty in the diagnosis and treatment of prostate cancer

transparent image

Surveilling Middle-Risk Prostate Cancer: Cautionary Data

transparent image

The ASCENDE-RT Study

transparent image

WORLD CANCER DAY – Let’s Get Talking About Cancer

transparent image

LDR brachytherapy: Past, present & future

transparent image

BXTAccelyon newsletter: January 2017

transparent image

BXTAccelyon support the fight against cancer

transparent image

Sydney siege survivor undergoes life-prolonging prostate cancer surgery

transparent image

Intermediate risk prostate cancer may be well controlled with brachytherapy alone

transparent image

BXTAccelyon newsletter: October edition

transparent image

Specialist nurses and the treatment of prostate cancer

transparent image

Cancer patients need to be made fully aware of the options available to them

transparent image

Gold Fiducial Markers – Now available to order with BXTAccelyon

transparent image

Tom Wolf talks about his prostate cancer to ABC 27 News

transparent image

Brachytherapy alone for intermediate-risk prostate cancer

transparent image

Raising awareness of prostate cancer

transparent image

‘Robotic surgery for prostate cancer no better than traditional surgery’

transparent image

LDR brachytherapy: the treatment pathway

transparent image

Is this the prostate cancer test all men at risk should demand?

transparent image

LDR brachytherapy making headlines

transparent image

Welcome to the BXTAccelyon newsletter

transparent image

How do I find out if I have prostate cancer?

transparent image

Wayne Sleep opens up about prostate cancer diagnosis which shook him ‘to the core’

transparent image

Australian hospital celebrates its 400th LDR brachytherapy patient

transparent image

First implant in BENELUX with BXTAccelyon supplied I-125 seeds, products and services

transparent image

Blasted by seeds: Tom McGrath’s Story

transparent image

Prostate Cancer: Signs & Symptoms

transparent image

March is Prostate Cancer Awareness Month

transparent image

4D Brachytherapy™ Lands in Australia

transparent image

LDR brachytherapy has emerged as the most effective treatment for long-term survival of prostate can

transparent image

About webBXT

transparent image

Hemiablative focal brachytherapy pilot study

transparent image

Recent Study Favors Brachytherapy in Treating Prostate Cancer

transparent image

The IsoLoader

transparent image

‘Magic’ Seeds

transparent image

Eckert & Ziegler to sell US seed business

transparent image

10 Things You Need To Know About LDR Brachytherapy

transparent image

All You Need To Know About 4D Brachytherapy

transparent image

Article claiming lower mortality for surgery verses radiotherapy could be misleading

transparent image

Cleveland clinic study favours brachytherapy in treating prostate cancer

transparent image

Blasted by Seeds – One Man’s Story of Beating Prostate Cancer with Brachytherapy

transparent image

World’s first 4D Brachytherapy implant using an IsoLoader

transparent image

Treatment for prostate cancer robs 100,000 Australian men of sex life

transparent image

Prostate cancer test which detects tumour size could save thousands of lives

transparent image

BXTAccelyon have moved!

transparent image

Family history of prostate cancer doesn’t mean higher risk of aggressive cancer

transparent image

Large variation in costs for low-risk prostate cancer treatment

transparent image

Edinburgh Cancer Centre: supporting open thinking in prostate cancer treatment options

transparent image

Not so new Faces! Ageing rockers Rod Stewart, Ronnie Wood, and Kenney Jones reunite their band after 40 years for special charity concert

transparent image

All Whites great Steve Sumner feeling positive after being given 30 per cent chance of beating prostate cancer

transparent image

Living with Cancer: 5 Important Questions

transparent image

Petition: National Prostate Cancer Screening for the UK

transparent image

History Lesson: Men Need to Know If Grandpa Had Prostate Cancer

transparent image

Five genetically-different types of prostate cancer identified

transparent image

ASCENDE RT study: intermediate and high risk prostate cancer patients have double the survival chance with brachytherapy seeds

transparent image

Implants boost odds of halting prostate cancer: Men treated with radioactive ‘seeds’ twice as likely to find disease has stabilised after five years

transparent image

Low dose treatment for prostate cancer may be twice as good

transparent image

Trial of radioactive implants offers improved prostate cancer survival

Sorry, there are currently no posts with that category.

Join us on Twitter

Have you been diagnosed with prostate cancer?

We’d appreciate 5 minutes of your time to answer our questionnaire